Abbott clinical biochemically activated aspartate transaminase assay set
Taiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Jan 12, 2022 – Jan 12, 2027Active- Analysis ID
- 1d08001a3e73e62c8174ee5798bd0ea6
- Customs Code
- DHA05603520402
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is used to quantify aspartate aminotransferase in human serum or plasma on the ARCHITECT c system.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1100 天門冬胺酸轉胺酶試驗系統
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Jan 12, 2022
- Expiry Date
- Jan 12, 2027
Access comprehensive regulatory information for Abbott clinical biochemically activated aspartate transaminase assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1d08001a3e73e62c8174ee5798bd0ea6 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.